High Throughput Screening Market Research Report Information By Product &AMP Service (Reagents &AMP, Assay Kits Instruments, Consumables &AMP, Accessories, Software and Services), By Technology (Cell-Based Assays, 2D Cell Culture, 3D Cell Culture [Scaffold-Based Technologies (Hydrogels Inert Matrix Micropatterned Surfaces)], Scaffold-free Technologies (Microplate), Hanging-drop Plates, Ultra-low Binding Plates, Other Scaffold-free Technologies), and By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Til

Global High Throughput Screening Market Overview

High Throughput Screening Market Size was valued at USD 8.2 billion in 2022 and is projected to grow from USD 17.45 Billion in 2023 to USD 112.8 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.12% during the forecast period (2023 - 2030). High throughput screening is a technique for discovering and developing novel drugs. The procedure encompasses several steps, including target identification, reagent preparation, compound management, assay development, and high-throughput library screening, which involves screening a sizable number of biological effectors and modulators against the desired substance. Methods for high-throughput screening are also useful in reducing the cost of drug development which is driving the high throughput screening market. These are just a few of the market drivers that are driving the market.

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

High Throughput Screening Market Trends

• Rising investment in research and development of new drugs to propel market growth

Open access to high-throughput screening laboratories, improvements in high-throughput screening technology, and rising use in universities and research facilities are some drivers boosting the market growth. The variety of public high-throughput screening (HTS) facilities has significantly increased during the last few years. These facilities come in a variety of sizes, from large molecular libraries and probe center networks to sparsely furnished university screening facilities. These labs offer a comprehensive approach to probe discovery in academia and conduct primary and secondary screening campaigns using both traditional and cutting-edge assay technology. Knowledge exchange among scientists, researchers, and others was one of these centers' key benefits. As an illustration, the Columbia Genome Center provides researchers across the Columbia University academic community with top-notch molecular screening services. Thus, this factor is driving the market CAGR.

Massive chemical and biomarker libraries created during the research processes have led to the adoption of automated high-throughput screening techniques to screen them. This is due to the growing need for rapid and accurate screening of several target molecules during drug discovery and development.

A June 2020 article titled "High-throughput screening as a strategy for discovering new medications" also claims that fluorescence-based assays are useful for visualizing biological reactions to chemicals in a high-throughput setting. Also, according to the same source, a target molecule can be created or removed in fluorescence investigations to release or quench signals. This is projected to enhance high-throughput screening techniques for creating new medications, likely to fuel market expansion. Thus, it is anticipated that this aspect will accelerate high throughput screening market revenue globally.

High Throughput Screening Market Segment Insights

High Throughput Screening Product &AMP Service Insights

The High Throughput Screening Market segmentation, based on product &AMP services, includes reagents &AMP, assay kits instruments, consumables &AMP, accessories, software and services. The consumables &AMP segment held the majority share in 2022 in the High Throughput Screening Market data The worldwide high-throughput screening market's consumables segment held the largest share. Several factors can explain this market's sizeable share, such as the vast use of reagents and assay kits in HTS techniques, expanding pharmaceutical R&D, and rising government financing for life sciences research.

August 2021: A high-throughput screening identifies compounds that specifically reduce viability in liver cancer cells with a high level of sall4 by inhibiting oxidative phosphorylation.

Figure 2: High Throughput Screening Market, by Product &AMP Services, 2022 & 2030 (USD Billion)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

High Throughput Screening Technology Insights

The High Throughput Screening Market segmentation, based on technology, includes Cell-Based Assays, 2D Cell Culture, 3D Cell Culture [Scaffold-Based Technologies (Hydrogels Inert Matrix Micropatterned Surfaces)], Scaffold-free Technologies (Microplate), Hanging-drop Plates, Ultra-low Binding Plates, Other Scaffold-free Technologies. The Cell-Based Assays segment dominated the market growth in 2022 and is projected to be the faster-growing segment during the forecast period, 2022-2030. More than 55.0% of the total income came from cell-based tests. Due to their capacity to produce visual data and test using the smallest possible amounts, fluorescent imaging plate reader assays have grown to be the most popular cell-based assays. The most recent technique, ultra-high throughput screening, produces more work in less time. Hence contributing in the growth of the high throughput screening market.

Most businesses are in the process of switching from 2D to 3D cell cultures as 3D cells exhibit more lifelike characteristics when tested in the natural environment and other cell-related manipulations, which are helpful for drug design and discovery.

February 2022: Bruker Corporation unveiled the timsTOF MALDI PharmaPulse (timsTOF MPP) system, a revolutionary new high-end solution for unbiased, deep HTS and uHTS based on label-free mass spectrometry.

High Throughput Screening Regional Insights

By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. North America High Throughput Screening market accounted for USD 3.75 billion in 2022 with a share of around 45.80% and is expected to exhibit a significant CAGR growth during the study period. Owing to the massive investments made by the pharmaceutical industry in high-throughput screening technologies in terms of automation, miniaturization, and assay methodology. Other factors include the growing adoption of high-throughput screening, rising research and development spending, and growing advancements in combinatorial chemistry and genomics. Recent increases in the amount of money that various pharmaceutical businesses and governmental agencies spend on research and development (R&D) are expected to fuel market expansion during the next years. For instance, Danaher Company increased its R&D spending from USD 1,348 million in 2020 to USD 1,742 million in 2021. New product development, partnerships, partnerships, expansions, mergers, and acquisitions are the main strategies used by the organisations in the market.

Further, the major countries studied in the market report are: The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 3: HIGH THROUGHPUT SCREENING MARKET SHARE BY REGION 2022 (%)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe High Throughput Screening market accounts for the second-largest market share. Because of improvements in chemical testing, the creation of hardware and software that can automate testing, government initiatives for drug testing, R&D by numerous research centers, and the growth in the use of data processing software for HTS, European markets account for a sizable portion of the market. Moreover, UK High Throughput Screening market held the largest market share, and the Germany High Throughput Screening market was the fastest growing market in the region.

Asia Pacific High Throughput Screening Market is expected to grow at the fastest CAGR from 2022 to 2030. High throughput screening methods are becoming more and more common in the Asia Pacific region. Compared to Bio-Rad Laboratories, Charles River Laboratories had higher total revenue in 2018 at $2.3 billion. 2018 saw $2.289B in revenue for Bio-Rad Laboratories. Further, the China High Throughput Screening market held the largest market share, and the India High Throughput Screening market was the fastest growing market in the region.

High Throughput Screening Key Market Players & Competitive Insights

Major market players are spending a lot of money on R&D to increase their product lines, which will help the High Throughput Screening market grow even more. Market participants are also taking a range of strategic initiatives to grow their worldwide footprint, with key market developments such as new product launches, mergers and acquisitions, contractual agreements, increased investments, and collaboration with other organizations. Competitors in the high throughput screening industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market environment.

One of the primary business strategies adopted by manufacturers in the global high throughput screening industry to benefit clients and expand the market sector is to manufacture locally to reduce operating costs. In recent years, high throughput screening industry has provided medicine with some of the most significant benefits. The High Throughput Screening market major player such as Aurora Biomed Inc, Danaher, PerkinElmer, Tecan, Hamilton, Axxam.

The American company Bio-Rad Laboratories, Inc. designs and produces specialized technology products for clinical diagnostics and life science research markets. In 2018 saw the announcement of Bio-Rad Laboratories Inc. of an expanded global collaboration with Abbott, giving Abbott's clients more access to Bio-quality Rad's assurance procedures.

With its corporate headquarters in Washington, D.C., the Danaher Corporation is an American multinational conglomerate. The business develops, produces, and sells industrial, commercial, professional, and medical goods and services. In 2021, Danaher Company spent USD 1,742 million on research and development, up from USD 1,348 in 2020.

Key Companies in the High Throughput Screening market includes

• Aurora Biomed Inc


• Danaher


• PerkinElmer


• Tecan


• Hamilton


• Axxam


• Merck Group


• Corning


• BioTek


• Beckman Coulter Inc.

High Throughput Screening Industry Developments

February 2022: The biopharma company, timsTOF MALDI PharmaPulse (timsTOF MPP) system, a ground-breaking new high-end option for unbiased, deep HTS and uHTS based on label-free mass spectrometry, was introduced by Bruker Corporation.

July 2022: Opera launched, a new cell analyzer from Evotech Technologies, allows for quick, high-content study of drug activity with sub-cellular precision.

August 2021: By preventing oxidative phosphorylation, new high-throughput screening finds substances that particularly decrease viability in liver cancer cells with a high amount of sall4.

High Throughput Screening Market Segmentation

High Throughput Screening Product &AMP Service Outlook (USD Billion, 2019-2030)

• Reagents & AMP


• Assay Kits Instruments


• Consumables &AMP


• Accessories


• Software and Services

High Throughput Screening Technology Outlook (USD Billion, 2019-2030)

• Cell-Based Assays


• 2D Cell Culture


• 3D Cell Culture [Scaffold-Based Technologies (Hydrogels Inert Matrix Micropatterned Surfaces)


• Scaffold-free Technologies (Microplate)


• Hanging-drop Plates


• Ultra-low Binding Plates


• Other Scaffold-free Technologies

High Throughput Screening Regional Outlook (USD Billion, 2019-2030)

• 
  

  North America

  
  
  
  
  • US
  
  
  • Canada
  
  
  
  

   

  
  


• 
  

  Europe

  
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  

   

  
  


• 
  

  Asia-Pacific

  
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Australia
  
  
  • Rest of Asia-Pacific
  
  
  
  

   

  
  


• 
  

  Rest of the World

  
  
  
  
  • 
    

    Middle East

    
    
  
  
  • 
    

    Africa

    
    
  
  
  • 
    

    Latin America